UK 11:12 Sunday, 18 October 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
The most read non-Tom article this week is Covid Vaccine – Is It The End of the Gold Bull-Market? by Nigel Somerville (for an unheard of fifth week in a row) at a terrific number one or at number five, including Bearcasts and Tom’s new shareshow.
The first non-Nigel non-Tom article is Synairgen – Where are we now with the one Covid play I liked? by Peter Brailey at number seven/number 14.
Which one is the best of the week? Tell me in the comments.* * *
The most-read articles this week were:
The most-listened to Bearcasts this week were:
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
